JP2008502694A5 - - Google Patents

Download PDF

Info

Publication number
JP2008502694A5
JP2008502694A5 JP2007516648A JP2007516648A JP2008502694A5 JP 2008502694 A5 JP2008502694 A5 JP 2008502694A5 JP 2007516648 A JP2007516648 A JP 2007516648A JP 2007516648 A JP2007516648 A JP 2007516648A JP 2008502694 A5 JP2008502694 A5 JP 2008502694A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutical composition
composition according
optionally substituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007516648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008502694A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/020978 external-priority patent/WO2006085932A2/en
Publication of JP2008502694A publication Critical patent/JP2008502694A/ja
Publication of JP2008502694A5 publication Critical patent/JP2008502694A5/ja
Withdrawn legal-status Critical Current

Links

JP2007516648A 2004-06-14 2005-06-14 ボリン酸錯体の抗ウイルス使用 Withdrawn JP2008502694A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (2)

Publication Number Publication Date
JP2008502694A JP2008502694A (ja) 2008-01-31
JP2008502694A5 true JP2008502694A5 (https=) 2008-07-31

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007516648A Withdrawn JP2008502694A (ja) 2004-06-14 2005-06-14 ボリン酸錯体の抗ウイルス使用

Country Status (12)

Country Link
US (1) US7393856B2 (https=)
EP (1) EP1765360B1 (https=)
JP (1) JP2008502694A (https=)
AT (1) ATE447960T1 (https=)
BR (1) BRPI0512049A (https=)
CA (1) CA2570577A1 (https=)
DE (1) DE602005017626D1 (https=)
ES (1) ES2333244T3 (https=)
MX (1) MXPA06014417A (https=)
PT (1) PT1765360E (https=)
TW (1) TW200612967A (https=)
WO (1) WO2006085932A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635840A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
PT1988779E (pt) 2006-02-16 2015-09-04 Anacor Pharmaceuticals Inc Moléculas pequenas contendo boro como agentes antiinflamatórios
WO2010018836A2 (ja) * 2008-08-11 2010-02-18 独立行政法人科学技術振興機構 ポリグルタミン凝集阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
MA38319A1 (fr) 2013-01-30 2016-08-31 Dow Agrosciences Llc Utilisation des benzoxaboroles à titre d'agents antimicrobiens volatils sur les viandes, les plantes, ou des parties de plantes
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
KR101756785B1 (ko) * 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
RS64770B1 (sr) 2016-03-07 2023-11-30 Agrofresh Inc Sinergistički postupci upotrebe jedinjenja benzoksaborola i gasova za prezerviranje kao antimikrobnih agenasa za useve
MA52337A (fr) 2017-03-01 2021-03-03 Anacor Pharmaceuticals Inc Nouveaux analogues d'oxaborole et utilisations de ces derniers
TWI883391B (zh) 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
EP4204012A1 (en) 2020-08-31 2023-07-05 Pfizer Inc. Methods of protecting rna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5920400A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Cell-based assay systems for examining hcv ns3 protease activity
EP1980564A1 (en) * 2002-12-18 2008-10-15 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use

Similar Documents

Publication Publication Date Title
JP2008502694A5 (https=)
JP2008543886A5 (https=)
JP2011026326A5 (https=)
JP2013056886A5 (https=)
JP2020534361A5 (https=)
JP2013519680A5 (https=)
JP2008523126A5 (https=)
JP2009513564A5 (https=)
JP2007512299A5 (https=)
JP2012530758A5 (https=)
JP2017538722A5 (https=)
WO2014130310A1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
NO20090172L (no) Substituert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
JP2009507896A5 (https=)
JP2009017881A5 (https=)
JP2009544635A5 (https=)
ZA200710513B (en) Control of parasites in animals by N-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and N-[(phenylsulfanyl)-phenyl]-1, 1, 1-trifluoromethanesulfonamide derivatives
JP2013537203A5 (https=)
JP2014500265A5 (https=)
JP2006143751A5 (https=)
JP2005518357A5 (https=)
HRP20160450T1 (hr) Novi inhibitori reduktaze s-nitrozoglutationa
JP2011503103A5 (https=)
JP2010525056A5 (https=)
JP2011521911A5 (https=)